AUTOIMMUNE DISEASES
Clinical trials for AUTOIMMUNE DISEASES explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE DISEASES trials appear
Sign up with your email to follow new studies for AUTOIMMUNE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can flu shots protect patients on immune drugs?
⭐️ VACCINE ⭐️ CompletedThis study looked at how well the seasonal and H1N1 flu vaccines work in 234 adults with autoimmune diseases like lupus or vasculitis, some of whom were taking steroids or other immune-suppressing medications. The goal was to measure the body's immune response and safety of the v…
Matched conditions: AUTOIMMUNE DISEASES
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:01 UTC
-
New blood filter shows promise for autoimmune patients
Disease control CompletedThis study looked at how safe and effective the GLOBAFFIN® blood filter is for people with autoimmune diseases. It involved 34 adults who were already scheduled to use the filter as part of their routine care. The main goal was to measure how much the filter lowered disease-relat…
Matched conditions: AUTOIMMUNE DISEASES
Phase: NA • Sponsor: Fresenius Medical Care Deutschland GmbH • Aim: Disease control
Last updated May 26, 2026 03:00 UTC
-
New drug VIS171 takes first step in human trials for autoimmune conditions
Disease control CompletedThis early-stage study tested a new drug, VIS171, in 61 people to see if it is safe. First, healthy volunteers received a single dose. Then, people with autoimmune diseases received multiple doses. The main goal was to check for side effects and how the drug affects immune cells.…
Matched conditions: AUTOIMMUNE DISEASES
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New antibody shows promise against rare kidney disease
Disease control CompletedThis study tested a new antibody drug (C5 monoclonal antibody) in 16 people with anti-GBM disease, a severe autoimmune condition that often leads to kidney failure. The goal was to see if the drug could improve kidney outcomes and reduce the need for dialysis or transplant. The t…
Matched conditions: AUTOIMMUNE DISEASES
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Rituximab shows lasting benefits for rare skin disease
Disease control CompletedThis study followed 80 adults with pemphigus, a rare autoimmune blistering skin disease, who had previously received rituximab in the Ritux 3 trial. Researchers tracked long-term side effects and how many patients stayed in remission over several years. The goal was to understand…
Matched conditions: AUTOIMMUNE DISEASES
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
One donor, two transplants: new hope for patients with blood cancer and kidney failure
Disease control CompletedThis study tested a combined bone marrow and kidney transplant from a partially matched family donor for 10 people with both a serious blood disorder and chronic kidney disease. The goal was to treat both conditions with one donor, potentially reducing the need for lifelong anti-…
Matched conditions: AUTOIMMUNE DISEASES
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Shocking away period pain: electrical acupoint therapy tested in autoimmune patients
Symptom relief CompletedThis study tested a non-invasive treatment called transcutaneous electrical acupoint stimulation (TEAS) to see if it can reduce pain and inflammation during menstruation in women with autoimmune diseases like rheumatoid arthritis or lupus. Fifty-two women with severe period pain …
Matched conditions: AUTOIMMUNE DISEASES
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated May 26, 2026 02:53 UTC
-
Coaching eases tough move to adult rheumatology care
Knowledge-focused CompletedThis study tested whether coaching sessions are practical for young people (ages 16-18) with rheumatic diseases like juvenile arthritis as they move from pediatric to adult rheumatology care. Researchers enrolled 26 participants and measured how many agreed to join, attended sess…
Matched conditions: AUTOIMMUNE DISEASES
Phase: NA • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated May 26, 2026 03:00 UTC
-
Massive study tests vitamin d and fish oil for autoimmune and knee pain relief
Knowledge-focused CompletedThis study looked at whether taking daily vitamin D or fish oil supplements could reduce the risk of autoimmune diseases, lower inflammation in the blood, and ease chronic knee pain. Over 25,000 adults without prior cancer or heart disease took part. Researchers measured inflamma…
Matched conditions: AUTOIMMUNE DISEASES
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:52 UTC
-
Molecular mapping may unlock personalized treatments for mysterious inflammatory illnesses
Knowledge-focused CompletedThis study tested whether analyzing a patient's DNA and RNA can help doctors choose the right targeted therapy for hard-to-classify inflammatory diseases affecting multiple organs. Researchers enrolled 32 adults with skin involvement and at least one other affected organ. The goa…
Matched conditions: AUTOIMMUNE DISEASES
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
Can cutting salt and sugar tame steroid side effects?
Knowledge-focused CompletedThis study looked at whether a diet low in salt and sugar can reduce common side effects of corticosteroid treatment, such as weight gain, high blood pressure, and diabetes. Fifty adults with autoimmune diseases or asthma who were starting high-dose corticosteroids took part. Res…
Matched conditions: AUTOIMMUNE DISEASES
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
New study reveals infection dangers of common autoimmune drug
Knowledge-focused CompletedThis study followed 73 people with autoimmune diseases like rheumatoid arthritis or multiple sclerosis who were starting treatment with rituximab. The goal was to track how many developed serious infections and identify what made some patients more at risk. Researchers also looke…
Matched conditions: AUTOIMMUNE DISEASES
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC
-
Healthy volunteers test new Drug's safety in Early-Stage trial
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles a new drug called RLYB116 in 16 healthy adults aged 18 to 55. Participants received multiple doses, and researchers monitored side effects, drug levels, and immune reactions. The goal was to gather safety informati…
Matched conditions: AUTOIMMUNE DISEASES
Phase: PHASE1 • Sponsor: Rallybio • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Scientists engineer 'smarter' IL-2 to tame overactive immune systems
Knowledge-focused CompletedThis study tested specially engineered versions of a natural immune protein (IL-2) in blood samples from 67 people with autoimmune or inflammatory diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal was to see if these modified proteins could selectively a…
Matched conditions: AUTOIMMUNE DISEASES
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:18 UTC